Ibutilide cardioversion of atrial fibrillation and atrial flutter and related affecting factors.docVIP
- 1、本文档共11页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Ibutilide cardioversion of atrial fibrillation and atrial flutter and related affecting factors
PAGE \* MERGEFORMAT 11
Ibutilide cardioversion of atrial fibrillation and atrial flutter and related affecting factors
[Abstract] Objective To observe the generation of class antiarrhythmic drug ibutilide and classic drugs amiodarone atrial fibrillation and atrial flutter effect. Methods May 2008 -2009 Division I in December into compliance with the treatment Case inclusion criteria were atrial fibrillation and atrial flutter in 44 cases, divided into two groups according to the order of admission, 22 cases of patients ibutilide, amiodarone group, 22 patients were intravenous ibutilide (1 or 2 times, intravenous injection of 1mg each), and amiodarone (1 to 2 times per 150mg intravenous injection) to observe the re-transfer rate and cardioversion time, record adverse reactions. ibutilide and amiodarone group results within 4h cardioversion to sinus rhythm were 81.8% and 40.9%, 24h, respectively, in cardioversion to sinus rhythm was 86.4% and 59.1%, the average recovery time were transferred (21 + -12) min and (48.5 + -18) min (P lt; 0.01). two fatal adverse events did not occur. Conclusion Ibutilide and amiodarone can terminate atrial fibrillation and atrial flutter, ibutilide cardioversion and sinus rhythm is more rapid, safe and effective.
[Keywords:] Ibutilide; amiodarone; atrial fibrillation; atrial flutter
To explore the ibutilide cardioversion of atrial fibrillation and atrial flutter antiarrhythmic efficacy, we conducted a clinical comparative study are as follows.
1 Materials and Methods
1.1 Case Selection The onset of atrial fibrillation or flutter duration of “90 days to patients; age of 40 to 75 years old, weighinggt; = 55kg; by type , class of antiarrhythmic drug therapy has been discontinued five half-lives of patients or above; with onset timegt; 48h persons have been given formal anticoagulation therapy. All patients signed the informed consent. rule out acute myocardial infarction, unstable angina pectoris; cardiac functiongt; =
您可能关注的文档
- Hypersensitivity syndrome after infection 1 case of nursing.doc
- Hypertension and vascular overload index patients with metabolic syndrome and left ventricular hypertrophy study.doc
- Hypertension on the clinical symptoms of the elderly.doc
- Hypertension in patients with various liver syndrome changes in oxidative stress function of the clinical observation.doc
- Hypertension PPAR gene expression in different syndromes and carotid artery remodeling.doc
- Hypertension risk factors and community-based prevention.doc
- Hypertension in the Elderly in the Community Health Education Western analysis of nutritional KAP.doc
- Hypertension Study of the effect of behavioral intervention in patients.doc
- Hypernatremia on the diagnosis and treatment.doc
- Hypertension in middle-aged self-care and drug intervention.doc
- 绿色建筑与乡村振兴融合的2025年技术应用示范项目.docx
- 绿色建筑与碳中和2025:建筑行业节能减排技术发展现状与挑战.docx
- 汽车与交通设备行业智能驾驶辅助系统市场应用案例报告.docx
- 公交公司场站保洁及物业维修服务公众管理制度.docx
- 高校产学研合作2025年技术转移与成果转化中的产学研合作项目绩效评估体系构建报告.docx
- 2025年中小企业数字化转型升级专项资金申请要点与成功案例报告.docx
- 2025年金融行业绿色金融发展报告:绿色债券与投资策略分析.docx
- 绿色建筑产业链协同效应评估体系构建与实证研究.docx
- 绿色建筑产业链协同创新与可持续发展研究.docx
- 2025年煤炭清洁利用技术突破与行业绿色发展路径研究报告.docx
文档评论(0)